header logo
  • The Avillion Effect
  • The Team
  • News
  • Contact
header logo
  • The Avillion Effect
  • The Team
  • News
  • Contact

News

Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients

7 October 2024Press Releases
Read More
CONTACT
+44 (0)203 764 9530
contact@avillionls.com
LinkedIn
footer logo
© Avillion Life Sciences. Registered in England and Wales No: 14549035
Privacy Policy | Cookie Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

popup logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Cookie Policy

More information about our Cookie Policy